The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000257.3(MYH7):c.2155C>T (p.Arg719Trp)

CA011779

14104 (ClinVar)

Gene: MYH7
Condition: hypertrophic cardiomyopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: 7b17a8bd-b169-46a1-8efa-b7388c4ecdef

HGVS expressions

NM_000257.3:c.2155C>T
NM_000257.3(MYH7):c.2155C>T (p.Arg719Trp)
NC_000014.9:g.23425971G>A
CM000676.2:g.23425971G>A
NC_000014.8:g.23895180G>A
CM000676.1:g.23895180G>A
NC_000014.7:g.22965020G>A
NG_007884.1:g.14691C>T
NM_000257.4:c.2155C>T
ENST00000355349.3:c.2155C>T

Pathogenic

Met criteria codes 8
PP1_Strong PS4 PS2 PS3 PP3 PM2 PM5 PM1

Evidence Links 11

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cardiomyopathy VCEP
The c.2155C>T (p.Arg719Trp) variant in MYH7 has been reported in >20 individuals with hypertrophic cardiomyopathy (PS4; PMID:9829907; PMID:8282798; PMID:9822100; PMID:12974739; PMID:22429680; PMID:23816408; PMID:12707239; PMID:19645038; PMID:27532257; SHaRe consortium, PMID: 30297972; Partners LMM ClinVar SCV000059419.5 ), including 1 de novo occurrence (PS2; 10957787). This variant was found to segregate with disease in 8 affected family members (PP1_Strong; PMID:9829907; PMID:8282798; PMID:9822100; PMID:12974739; SHaRe consortium, PMID: 30297972). A mouse model indicates that this variant disrupts the function of MYH7 and leads to a phenotype consistent with HCM (PS3: PMID:24829265). This variant was absent from large population studies (PM2; http://exac.broadinstitute.org). This variant lies in the head region of the protein (aa 181-937) and missense variants in this region are statistically more likely to be disease-associated (PM1; PMID:27532257). Computational prediction tools and conservation analysis suggest that this variant may impact the protein (PP3). A different pathogenic missense variant has been previously identified at this codon which may indicate that this residue is critical to the function of the protein (PM5; c.2156G>A p.Arg719Gln - Variation ID 14107). In summary, this variant meets criteria to be classified as pathogenic for hypertrophic cardiomyopathy in an autosomal dominant manner. MYH7-specific ACMG/AMP criteria applied (PMID:29300372): PS2; PS3; PS4; PP1_ Strong; PM1; PM2; PM5; PP3
Met criteria codes
PP1_Strong
8 segregations (including SHaRe data)

PS4
>20 probands with HCM (icluding SHaRe data and ClinVar SCV000059419.5)

PS2
1 de novo occurrence with paternity confirmed

PS3
Mice heterozygous for the R719W variant develop progressive concentric hypertrophy. Homozygous mice died within 9 days of birth.

PP3
Tools predict damaging
PM2
Absent from ExAC
PM5
c.2156G>A (p.Arg719Gln) - Variation ID 14107 - Pathogenic by Expert Panel
PM1
Variants in head region of the protein (aa 181-937) are statistically more likely to be disease-associated

Approved on: 2016-12-15
Published on: 2018-11-16
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.